Key result
Minimally invasive epicardial clipping of the left atrial appendage achieved successful exclusion (residual sac <1 cm) in 100% of 24 high-risk patients with atrial fibrillation.
Why the study?
Does minimally invasive epicardial clipping successfully exclude the left atrial appendage in high-risk patients with atrial fibrillation who cannot tolerate anticoagulation?
Observational (n=24)
Does minimally invasive epicardial clipping successfully exclude the left atrial appendage in high-risk patients with atrial fibrillation who cannot tolerate anticoagulation?
Minimally invasive epicardial clipping of the LAA is feasible and achieves successful short-term exclusion in high-risk AF patients who cannot tolerate anticoagulation.
Demonstrates feasibility of minimally invasive LAA clipping in high-risk AF; hypothesis-generating, requiring prospective trials before adoption.
OBJECTIVE: Atrial fibrillation (AF) is the primary cardiac abnormality associated with ischemic stroke. Atrial fibrillation affects 2.7 million people with a stroke rate of 3.5% per year. Most of the emboli in patients with nonvalvular AF originate in the left atrial appendage (LAA). Surgical exclusion of the LAA decreases the yearly risk of stroke to 0.7% when combined with a Maze procedure. Traditional oversewing the LAA from inside the left atrium is associated with a significant number of recanalizations of LAA. An alternate technique is epicardial clipping, which has been approved through sternotomy for permanent exclusion of LAA. We present our initial experience of epicardial clipping of the LAA using a minimally invasive approach. METHODS: Between May 2012 and December 2015, a total of 24 consecutive patients underwent minimally invasive, echo-guided epicardial clipping. Indications for the procedure were persistent (n = 12) or paroxysmal (n = 12) AF in patients who could not tolerate full anticoagulation because of a combination of gastrointestinal bleeding (n = 7), hemorrhagic stroke (n = 5), ischemic stroke (n = 5), intramuscular bleeding (n = 3), falls (n = 2), urinary tract bleeding (n = 2), subdural hematoma (n = 1), traumatic aortic intramural hematoma (n = 1), and lifestyle and career practices inconsistent with anticoagulation (n = 1). The clipping was performed through three 5-mm ports in the left seventh intercostal space (n = 22) or a 5-cm incision in the fifth intercostal space (n = 2). Echocardiography was performed to exclude the presence of LAA thrombus and to confirm exclusion of LAA before final deployment of the clip. RESULTS: The mean age was 73.6 years. The mean CHA2DS2VASC score was 4.7 and the mean HAS-BLED score was 3.8. The mean postoperative length of stay was 6.4 days. One patient died of stroke-related complications 10 days after successful clipping, and two patients required thoracentesis to drain recurrent pleural effusions. All patients had successful exclusion of LAA defined as residual sac of less than 1 cm. CONCLUSIONS: Isolated epicardial left atrial clipping is a safe treatment option in high-risk patients with AF. Long-term success in preventing stroke is still to be determined, but short-term results are very encouraging.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2017) conducted an observational in Atrial fibrillation (n=24). Minimally invasive epicardial clipping of the left atrial appendage was evaluated on Successful exclusion of LAA defined as residual sac of less than 1 cm. Minimally invasive epicardial clipping of the left atrial appendage achieved successful exclusion (residual sac <1 cm) in 100% of 24 high-risk patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: